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Abstract
Background: Our goal was to quantify the evidence that is available to the physicians of a pediatric
emergency department (PED) in making treatment decisions. Further, we wished to ascertain what
percentage of evidence for treatment provided in the PED comes from pediatric studies.
Methods: We conducted a retrospective chart review of randomly selected patients seen in the
PED between January 1 and December 31, 2002. The principal investigator identified a primary
diagnosis and primary intervention for each chart. A thorough literature search was then
undertaken with respect to the primary intervention. If a randomized control trial (RCT) or a
systematic review was found, the intervention was classified as level I evidence. If no RCT was
found, the intervention was assessed by an expert committee who determined its appropriateness
based on face validity (RCTs were unanimously judged to be both unnecessary and, if a placebo
would have been involved, unethical). These interventions were classified as level II evidence.
Interventions that did not fall into either above category were classified as level III evidence.
Results: Two hundred and sixty-two patient charts were reviewed. Of these, 35.9% did not
receive a primary intervention. Of the 168 interventions assessed, 80.4% were evidence-based
(level I), 7.1% had face validity (level II) and 12.5% had no supporting evidence (level III). Of the
evidence-based interventions, 83.7% were supported by studies with mostly pediatric patients.
Conclusion: Our study demonstrates that a substantial proportion of PED treatment decisions
are evidence-based, with most based on studies in pediatric patients. Also, a large number of
patients seen in the PED receive no intervention.
Background
The term "evidence-based medicine" has become a catch-
phrase for the twenty-first century. Physicians are being
called upon to justify their treatment decisions with valid,
up-to-date evidence. There have been attempts within
many areas of medicine to quantify the evidence that is
available to, and used by, the physicians of that discipline.
The first such study, conducted by Ellis et al [1] in 1995,
found that 82% of treatments in internal medicine were
evidence-based. This study has been replicated among a
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variety of disciplines, including family medicine [2] (81%
evidence-based interventions), hematology [3] (70% evi-
dence-based interventions), and surgery [4] (45% inter-
ventions based on randomized control trial [RCT]
evidence or better).
Within pediatrics, there have been three such studies.
Moyer et al [5] examined pediatric inpatients and found
that 75% of primary interventions were supported by evi-
dence. Rudolf et al [6] found 40% of clinical actions in a
community-based pediatric practice were supported by
RCT evidence and 7% were supported by convincing non-
experimental evidence. In a study of pediatric surgical
patients, Baraldini et al [7] found that only 29% of their
treatments were based on level I or II evidence, as defined
by Ellis et al (described below).
There is a need to investigate whether and to what extent
the treatment of pediatric emergency patients is based on
evidence. The wide variety of ailments seen within this
area should offer a more comprehensive assessment of the
overall state of evidence within pediatrics – encompassing
surgical, outpatient and inpatient medicine, across all
ages. At the same time, we need to gain an understanding
of the quality and quantity of evidence in existence to sup-
port pediatric clinical decisions. How often is adult evi-
dence generalized to the treatment of children? This is an
important issue given that children differ from adults in
terms of their physiology, biology, and developmental
processes. There is limited health information available
from research in children and, as a result, health care pro-
viders repeatedly turn to other sources of evidence, such as
adult studies, to assist with managing health care issues in
children [8].
In the present study, we sought to identify the extent to
which evidence exists for use within the unique environ-
ment of the pediatric emergency department. A secondary
objective was to determine the amount of evidence,
applied to pediatrics, that is derived from adult studies.
We hypothesized, a priori, that this was a common prac-
tice within pediatrics. Our hope was to identify areas
within the body of evidence for pediatric emergency med-
icine that require future study.
Methods
This study was approved by the Health Research Ethics
Board at our institution.
We conducted a retrospective chart review of randomly
selected patient charts based on patients seen in a Pediat-
ric Emergency Department at a tertiary care facility during
the 2002 year (January 1 to December 31). The sampling
frame was created using the Emergency Department Infor-
mation System (EDIS) database. The following variables:
hospital record number, patient hospital number, patient
visit number, date, time, and age made up the sampling
frame. A random sample of patient visits were then gener-
ated using random-number computer software (S-plus
6.0). Any individual patient was included only once in the
sample. A sample size calculation of 295 showed that a
minimum of 5.6% precision would be achieved for any
given estimate of percentage. The primary investigator
(PI) retrospectively reviewed the sampled records and,
using a standardized abstraction form, identified a pri-
mary diagnosis and primary intervention for each based
on the definition set out by Ellis et al. That is, the primary
diagnosis was defined as "the disease, syndrome or condi-
tion entirely or, if there were several diagnoses, [the diag-
nosis] most responsible for the patient's [visit to the
pediatric emergency department]" [1]. The PI used infor-
mation from the emergency physician's notes, lab and
radiographic results, and any other relevant documenta-
tion from the emergency room visit to establish this. If
conflicting information was present on the chart, the final
diagnosis, as described at the bottom of the emergency
record form, was used.
The primary intervention was taken to be "the treatment
or other maneuver that represented our most important
attempt to cure, alleviate, or care for the patient [with
respect to] his or her primary diagnosis" [1]. This was also
determined by the PI based on the patient's chart.
A thorough literature search was then undertaken with
respect to the primary interventions. Current (at the time
of searching) MEDLINE, EMBASE and the Cochrane
Library databases were searched comprehensively to
determine if any evidence existed with respect to the indi-
vidual primary interventions. Abstracts and references of
relevant scientific papers were also searched. Local experts
were contacted and asked if they were aware of RCTs in
existence that had not yet been published or that were not
found through the search strategy (this step yielded no
additional information).
The primary interventions were then divided into the fol-
lowing categories that have been used in previous research
[1-4].
Level I evidence
The abstract or paper demonstrated that this intervention
had been evaluated in an RCT, systematic review or meta-
analysis. No attempt was made to rate the quality of the
study or its findings as this did not relate directly to our
goal of determining the quantity of evidence available to
PED physicians.BMC Pediatrics 2006, 6:26 http://www.biomedcentral.com/1471-2431/6/26
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Level II evidence
No abstract or paper could be found that investigated this
intervention in an RCT, systematic review or meta-analy-
sis. However, a committee determined there to be con-
vincing non-RCT evidence for this intervention. That is,
the face validity of such an intervention was considered to
be so great that randomized trials were unanimously
judged to be unnecessary or, if a placebo were to be
involved, potentially harmful (i.e., giving a blood transfu-
sion to a patient who was exsanguinating [1]). The com-
mittee for this study was made up of five pediatric
emergency physicians with extensive experience in pediat-
ric emergency medicine and evidence-based medicine,
one of whom was a co-investigator. The remainder of the
committee had no other involvement in the study and
was provided with only the definitions of the levels of evi-
dence and a brief synopsis of the patient visit. Only unan-
imous committee decisions were considered sufficient for
the inclusion of the intervention as level II evidence.
Level III evidence
No abstract or paper could be found that involved this
intervention in an RCT, systematic review or meta-analy-
sis and the committee did not unanimously agree that
there was convincing non-RCT evidence to support it.
Level I evidence was further subdivided into those studies
that included a majority (i.e., more than 50%) of pediatric
patients and those that did not. Systematic reviews and
meta-analyses were included under the "pediatric studies"
grouping if they included one RCT of predominantly
pediatric patients. Every attempt was made to search out
pediatric studies, even if an adult RCT was found first for
any given intervention.
A further category was included of those patients who
received no primary intervention. This category included
patients who were discharged from the pediatric emer-
gency department after receiving only reassurance and/or
advice. The percentage of primary interventions which
were included in each category was calculated as was the
percentage of primary interventions deemed to be from
pediatric and adult studies, along with their exact 95%
confidence intervals [9].
Results
From the 18,855 patient visits to the PED during the year
January 1, 2002 and December 31, 2002, a random sam-
ple of 295 patient charts was computer generated, repre-
senting approximately 1% of patient visits. Any individual
patient was only included once in the sample. Of these
295 charts, 272 (92.2%) were available to be viewed. The
other 23 were missing from the chart area. Of the 272, 10
were discarded because of insufficient information to
determine a primary diagnosis and intervention (i.e. the
emergency record was missing from the chart). Ninety-
four patients received no intervention, representing
35.9% of our sample (95% CI 29.9 to 41.9).
Table 1 lists the interventions that qualified as level I evi-
dence, based on the finding of at least one RCT or SR. In
total, 135 patients were found to have received evidence-
based interventions (level I evidence), representing 80.4%
(CI 73.4 to 85.9) of patients who received interventions
and 51.5% of our sample.
The most common interventions were analgesics for mus-
culoskeletal pain (17/135 = 12.6%) and inhaled beta-ago-
nist for asthma exacerbations (12/135 = 8.9%); both were
supported by pediatric RCTs. Out of the 135 patients who
received interventions that were based on level I evidence,
113 patients' interventions (83.7%; CI 76.1 to 89.3) were
supported by pediatric RCTs.
The interventions unanimously determined, by the five
person committee of pediatric emergency department
(PED) physicians, to be worthy of level II evidence status
are listed in Table 2. Overall, 7.1% (CI 3.9 to 12.4) of
interventions, representing 4.6% of the sample, had face
validity worthy of level II evidence.
Including level I and II evidence, 87.5% (CI 81.3 to 91.9)
of interventions can be considered evidence-based.
Those interventions which were not considered to be evi-
dence-based (level III evidence) are listed in Table 3.
Twelve point five percent (CI 8.1 to 18.7) of interventions
(8.0% of the sample) fit into this category.
Discussion
The results of this study are important for several reasons.
First, we have shown that a substantial proportion of the
children seen in the PED do not receive any treatment or
intervention. In this sample of 1.4% of all PED visits over
one year, 35.9% of children received only reassurance or
advice. One of the most common reasons that children
were seen in the PED without intervention was upper res-
piratory tract infection (26%) (data not shown), usually
associated with fever. This leaves one wondering whether
parental education about benign fever and supportive
care for upper respiratory tract infection could help
shorten PED wait times. Studies on the effect of education
in this area could have very important beneficial effects in
terms of costs to the healthcare system.
Our study has revealed that a great majority of interven-
tions in the PED are based on pediatric studies (83.7%).
Although this is a positive finding, there are several areas
of pediatric medicine, such as migraine treatment and
fracture management, for which treatment continues toBMC Pediatrics 2006, 6:26 http://www.biomedcentral.com/1471-2431/6/26
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Table 1: Diagnoses and Interventions seen in the PED for which there is Level I Evidence
Diagnosis Intervention Number of Patients Reference
Evidence from Pediatric Studies
msk pain/soft tissue injury analgesic 17 Clark 2003[10]
Asthma exacerbation inhaled β-agonist 12 Travers 2001[11]
radial fracture reduction & cast 10 McLauchlan 2002[12]
otitis media PO antibiotics 10 Kozyrskyj 2000[13]
dehydration (failed PO rehydration) IV rehydration 6 Atherly-John 2002[14]
bronchiolitis salbutamol 6 Kellner 2000[15]
dehydration PO rehydration 5 Atherly-John 2002[14]
urinary tract infection PO antibiotics 5 Hoberman 1999[16]
constipation suppository/enema 5 Dashshan 1999[17]
laceration sutures 4 Barnett 1998[18]
croup PO steroids 4 Ausejo 2000[19]
suspected occult bacteremia IM/IV antibiotics 3 Bass 1993[20]
tonsillitis PO antibiotics 3 Del Mar 2000[21]
urticaria cetirizine 2 Simons 2000[22]
Kawasaki Syndrome IVIG & ASA 2 Newburger 1986[23]
alcohol intoxication intubation 2 Gausche-Hill 2000[24]
generalized tonic-clonic seizure in known epileptic increase clobazam dose 1 Booth 1998[25]
radial head subluxation reduction by hyperpronation 1 Macias 1998[26]
epistaxis silver nitrate 1 Ruddy 1991[27]
behavior problems referral for counselling 1 Dishion 1995[28]
bronchiolitis racemic epinephrine 1 Menon 1995[29]
viral conjunctivitis polysporin ointment 1 Isenberg 2002[30]
laceration tissue glue 1 Barnett 1998[18]
constipation polyethylene glycol 1 Dashshan 1999[17]
dog bite IV antibiotics & debridement 1 Medeiros 2001[31]
burn delayed graft 1 Desai 1991[32]
reflux esophagitis conservative reflux measures 1 Craig 2004[33]
pain (following MVC trauma) morphine infusion 1 Hendrickson 1990[34]
reflux esophagitis ranitidine 1 Cucchiara 1993[35]
varicella zoster supportive care 1 Klassen 2002[36]
atopic dermatitis hydrocortisone cream 1 Alonso 1999[37]
meningitis exposure (H flu) PO antibiotics 1 Daum 1981[38]
dislocated patella relocation under sedation 1 Nikku 1997[39]
Evidence from Adult Studies
migraine headache metoclopramide 3 Colman 2003[40]
proximal humerus fracture cast & sling 3 Gibson 2003[41]
ankle fracture cast 2 Phillips 1985[42]
gastritis antacids 1 Moayyedi 2003[43]
clavicle fracture sling 1 Andersen 1987[44]
prozac overdose (2 hours previous) supportive care 1 Yeates 2000[45]
tibial fracture internal fixation 1 Wyrsch 1996[46]
epididymitis PO antibiotics 1 Redfern 1984[47]
panic attack sublingual short-acting benzodiazepine 1 Dunner 1986[48]
aphthous ulcers viscous lidocaine 1 Saxen 1997[49]
fracture T12 vertebrae T11–12 instrumentation & fusion 1 Shen 2001[50]
aggression haloperidol & lorazepam 1 Gillies 2001[51]
tibial fracture reduction & cast 1 Abdel-Salem 1991[52]
acetaminophen overdose N-acetylcysteine 1 Brok 2002[53]
gastrostomy tube fell out insertion of foley catheter 1 Kadakia 1994[54]
increased intracranial pressure mannitol 1 Schierhout 2003[55]
migraine headache NSAID 1 Bussone 1999[56]
msk = musculoskeletal; PO = by mouth; IV = intravenous; IM = intramuscular, MVC = motor vehicle collision; NSAID = non-steroidal anti-
inflammatory; T12 = 12th thoracic vertebrae; IVIG = intravenous immunoglobulin; ASA = aspirin; H flu = Haemophilus influenzaeBMC Pediatrics 2006, 6:26 http://www.biomedcentral.com/1471-2431/6/26
Page 5 of 8
(page number not for citation purposes)
be based on adult studies. Ideally, we would like to see
100% of pediatric interventions based on pediatric stud-
ies.
A comparison of our results to similar studies is shown in
Table 4. Interestingly, our total "evidence-based" inter-
ventions (level I and II) at 56.1% is substantially less than
that found in similar studies in inpatient general medicine
[1] (82%) and inpatient pediatrics [5] (75%). However, a
closer look reveals that the discrepancy between this and
previous studies is not in the number of interventions
which involved an RCT (51.5% vs. 53% for Ellis and 31%
for Moyer) but in the number of interventions meeting
the criteria for level II evidence (4.6% vs. 29% for Ellis and
44% for Moyer).
If one compares what was categorized as level II evidence
by Moyer's study with our study, there are important dif-
ferences. For example, interventions such as IV rehydra-
tion and antibiotics for urinary tract infection, categorized
as level II evidence in the Moyer study, were classified as
level I evidence in our study. This may be a reflection of
the four year difference between studies and the accumu-
lation of research evidence during that time. Alternatively,
our study involved not only inpatients, but also patients
discharged directly from the PED. Therefore, interven-
tions which have been better studied such as antibiotics
for otitis media [13] and glucocorticoids for croup [19]
were included in our study. There were also differences
with respect to those interventions that were considered to
be worthy of level II evidence status by Dr Moyer's group
and which our group relegated to level III evidence. This
may simply be due to the degree of specificity involved in
labeling interventions. Antibiotics for pneumonia and
cellulitis were two such examples. Although our group
refused to agree that intravenous antibiotics were required
for these diagnoses, they certainly agreed treating a bacte-
rial infection with some form of antibiotics was com-
pletely valid. It is interesting to note that something as
simple as inserting the label "IV" or "PO" into the inter-
vention could affect the level of evidence that treatment
attained.
Table 3: Diagnoses and Interventions seen in the PED for which there is Level III Evidence
Diagnosis Intervention Number of Patients Committee Comments
femur shaft fracture closed reduction & spica cast 1 could likely do an RCT of open vs 
closed reduction
metatarsal fracture cast 1 one dissentor from the committee
contusion hand volar slab 1
sprained digit aluminum splint 2 would make a good RCT vs. placebo
non-displaced fracture thumb metacarpal bone thumb splint 1
cellulitis PO antibiotics 1 RCT needed for PO vs IV antibiotics
cellulitis IV antibiotics 3 RCT needed for PO vs IV antibiotics
pneumonia PO antibiotics 5 need higher quality of evidence as we 
probably over-treat
pneumonia IV antibiotics 3 see above comment
intussusception air contrast enema 1 need an RCT of air contrast vs barium 
enema
dental abscess drainage & PO antibiotics 1
erythema multiforme reactine (cetirizine) 1 Needs to be studied
Table 2: Diagnoses and Interventions seen in the PED for which there is Level II Evidence
Diagnosis Intervention Number of Patients
Ventriculo-Peritoneal shunt malfunction Ventriculo-Peritoneal shunt revision 1
cast broken replace cast 1
multiple phalangeal fractures volar splint hand and f/u with plastics 1
foreign body in foot removal of foreign body 2
non-displaced supracondylar fracture backslab and sling 1
non-displaced olecranon fracture Cast 1
late lateral condyle fracture open reduction with internal fixation 1
4th & 5th proximal phalangeal fractures ulnar gutter 1
abscess lower leg drainage & antibiotics 1
factor nine deficiency factor nine infusion 1
Wilm's tumour radical nephrectomy 1BMC Pediatrics 2006, 6:26 http://www.biomedcentral.com/1471-2431/6/26
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The limitations of this study are similar to those found
with the studies previously carried out in other disciplines
[1-5]. Certainly, there was the potential for the committee
to be biased when assigning the level of evidence based on
personal knowledge of the cases or personal treatment
preferences. This situation was minimized by employing
a committee of five physicians and requiring group una-
nimity for placing an intervention in the level II category.
One might argue that all members of the committee had
an inclination to prefer to categorize interventions as level
II, simply based on their own positions as PED physicians.
However, this was not proven true as we had substantially
fewer interventions placed in the level II category com-
pared to previous studies.
Another potential limitation is derived from the inclusion
of interventions under the category of level I evidence
without interpreting the results of the RCT. This was done
in order to compare our results to the original study by
Ellis which, likewise, did not comment on the content of
level I evidence.
Finally, while this was a random sample, it represented
only 1% of all PED patients seen over the course of a year,
therefore it provides an estimate of the proportion of PED
treatments that are evidence-based but may not be repre-
sentative of the full spectrum of different presenting con-
ditions.
There were many strengths of our study when compared
to previous studies. The relative inflexibility of our expert
panel in committing interventions to the level II evidence
group is one positive feature. Although there must be sub-
jectivity in a process such as this, our team was quite rig-
orous in applying the criteria for this category and limited
what must be assigned to this group accordingly. This is
reflected in the lower percentage of interventions ranked
as level II evidence by our committee (5% compared to
44% in the Moyer study [5]) than those previous. When
consensus surrounding the validity of a treatment without
RCT evidence is sufficient to warrant the label "level II evi-
dence", certainly there should be a very limited number of
interventions that will fit into this category. Another
strength was that our study sample was derived from a full
year of PED visits which would account for seasonal vari-
ation of presenting diagnoses. This made for a more accu-
rate representation of the most common diagnoses and
interventions seen within the pediatric emergency depart-
ment. We would expect the results of our 1% sample to be
relatively generalizable to any tertiary care pediatric cen-
tre. Finally, the search for evidence was exhaustive, mak-
ing it unlikely that relevant RCTs, which had been
published at the time of this study, were simply not found
during the literature search.
Conclusion
We have shown that a surprisingly large proportion of
patients seen in the pediatric emergency department
(35.9%) receive no intervention, while approximately
half of patients in this setting receive interventions that are
based on evidence from randomized controlled trials
(level I evidence). The vast majority of these are derived
from randomized control trials containing a majority of
pediatric patients. Although our study speaks positively of
the breadth of knowledge within the unique environment
of the pediatric emergency department, we have also iden-
tifed numerous important areas for future study within
pediatric research.
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